’ This causes case look at solution construction of recent proteins by case study solution plant that in turn causes case examine answer advancement of antibodies against case study answer anthrax bacterium, when fed on. 16 Trials have started on genetically engineered vegetation designed for ‘curative wounds and treating circumstances similar to cystic fibrosis, cirrhosis of case examine answer liver and anaemia; antibodies to fight melanoma and vaccines towards rabies, cholera and foot and mouth sickness. ’ 15The idea of genetically engineered vegetation for pharmaceutical use is a reasonably new idea, and hence such products are nonetheless in their preliminary levels of layout and checking out. However huge concern has been raised surrounding their use and feasible penalties. For example it’s far conception that food plants already are or may in case look at answer destiny, be ‘contaminated by DNA sequences from GM vegetation. ’ 15 Genetically modified crops run case examine answer risk of finally introducing unknown, probably harmful chemicals into case look at solution food chain, by accidental go breeding and seed infection. The registration statementof which this prospectus forms a part also registers on behalf of promoting stockholders a complete of 1,076,000 stocks of our commonstock bought from us in a personal placement among August 2012 and January 2013. The stocks of our common stock offered bythe promoting stockholders aren’t part of or conditioned on case look at solution closing of our public offering. Accordingly, case look at answer revenue cost tothe public by case look at answer promoting shareholders is fixed at $1. 00 per share for case study answer period of case examine solution Offering. We won’t acquire any proceedsfrom case look at solution sale of case study answer 1,076,000 stocks sold by case look at answer selling shareholders. This secondary providing will terminate upon case study answer earliestof i such time as all of case study solution average stock has been sold pursuant to case study solution registration statement or ii 180 days from case examine answer effectivedate of this Prospectus.
’ This causes case look at solution construction of recent proteins by case study solution plant that in turn causes case examine answer advancement of antibodies against case study answer anthrax bacterium, when fed on. 16 Trials have started on genetically engineered vegetation designed for ‘curative wounds and treating circumstances similar to cystic fibrosis, cirrhosis of case examine answer liver and anaemia; antibodies to fight melanoma and vaccines towards rabies, cholera and foot and mouth sickness. ’ 15The idea of genetically engineered vegetation for pharmaceutical use is a reasonably new idea, and hence such products are nonetheless in their preliminary levels of layout and checking out. However huge concern has been raised surrounding their use and feasible penalties. For example it’s far conception that food plants already are or may in case look at answer destiny, be ‘contaminated by DNA sequences from GM vegetation. ’ 15 Genetically modified crops run case examine answer risk of finally introducing unknown, probably harmful chemicals into case look at solution food chain, by accidental go breeding and seed infection. The registration statementof which this prospectus forms a part also registers on behalf of promoting stockholders a complete of 1,076,000 stocks of our commonstock bought from us in a personal placement among August 2012 and January 2013. The stocks of our common stock offered bythe promoting stockholders aren’t part of or conditioned on case look at solution closing of our public offering. Accordingly, case look at answer revenue cost tothe public by case look at answer promoting shareholders is fixed at $1. 00 per share for case study answer period of case examine solution Offering. We won’t acquire any proceedsfrom case look at solution sale of case study answer 1,076,000 stocks sold by case look at answer selling shareholders. This secondary providing will terminate upon case study answer earliestof i such time as all of case study solution average stock has been sold pursuant to case study solution registration statement or ii 180 days from case examine answer effectivedate of this Prospectus.